Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERSHEY COHSY · Entity 795 | Director | April 01, 2021 | April 05, 2021 |
| PITNEY BOWES INC /DE/PBI · Entity 4392 | Director | April 28, 2023 | May 01, 2023 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERSHEY CO
Report date April 01, 2021 · Filed April 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,342.0986 |
Reported balance
After 2021-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-04-01 · Grant · Acquired 129.623 · Balance 16,342.0986 F1: The total amount of securities reported as directly owned in Column 5 includes 84.2015 shares acquired on March15, 2021, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The total amount of securities reported as directly owned in Column 5 includes 84.2015 shares acquired on March15, 2021, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders.
PITNEY BOWES INC /DE/
Report date April 28, 2023 · Filed May 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,802.9519 |
Reported balance
After 2023-04-28 transaction · row 1
1 source rowRow 1 · 2023-04-28 · Grant · Acquired 19,802 · Balance 134,802.9519 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-04-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-04-28 · Exercise / conversion · Disposed 19,802 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock.
F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan).
Teladoc Health, Inc.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,266 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 29,986 · Balance 61,266 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 28,986 · Balance 0 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 30,441 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Grant · Acquired 30,441 · Balance 30,441 F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026.
F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date December 31, 2007 · Filed January 03, 2008
Section 16 reporting ended · disclosed 2008-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 97,933 |
Reported balance
After 2007-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2007-12-31 · Grant · Acquired 384 · Balance 97,933 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2019 Filed May 7, 2019 16:50 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionRestricted Stock Units · Derivative | 11,351 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-002670 · primarydocument.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,351 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The RSUs were granted on May 7, 2018 and have a one year cliff vesting. F1 · derivative.expiration_date: The RSUs were granted on May 7, 2018 and have a one year cliff vesting. Read SEC document |
| May 03, 2019 Filed May 7, 2019 16:50 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantCommon Stock | 11,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-002670 · primarydocument.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,943.6636 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 13:53 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 339.525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014401 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,592.2856 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 84.9685 shares acquired on March 15, 2019, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 17:28 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 363.713 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000518 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,167.7921 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 83.3431 shares acquired on December 14, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 17:52 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 380.237 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-028949 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,720.736 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 83.7029 shares acquired on September 14, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 13:29 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 413.466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022408 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,256.7961 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 120.7017 shares acquired on June 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007967 · edgar.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 Underlying: Common Stock · 1,965 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F1 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F1 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 4,082 | $0.00 Strike: $50.90 | $0.00 |
DisclosureSEC source: 0001179110-18-007967 · edgar.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,082 Underlying: Common Stock · 4,082 shares Expires 2028-05-31 F2 · derivative.exercise_date: The option vests in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 25, 2018 Filed May 30, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007682 · edgar.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 918 restricted stock units, vesting in full on May 25, 2018. F2 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 918 restricted stock units, vesting in full on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007682 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 24, 2018 Filed May 29, 2018 19:21 UTC | HERSHEY CO HSY · Entity 795 | SaleCommon Stock | 5,450 | $91.25 | $497,312.50 |
DisclosureSEC source: 0001127602-18-019041 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,722.6284 Read SEC document |
| May 07, 2018 Filed May 8, 2018 20:17 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantRestricted Stock Units · Derivative | 11,351 | $8.81 | $100,002.31 |
DisclosureSEC source: 0001562180-18-002360 · primarydocument.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,754 Underlying: Common Stock · 11,351 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F3 · deemedExecutionDate: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. Read SEC document |
| May 04, 2018 Filed May 8, 2018 20:17 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionRestricted Stock Units · Derivative | 6,309 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-002360 · primarydocument.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,403 Underlying: Common Stock · 6,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The RSUs were granted on May 8, 2017 and have a one year cliff vesting. F1 · derivative.expiration_date: The RSUs were granted on May 8, 2017 and have a one year cliff vesting. Read SEC document |
| May 04, 2018 Filed May 8, 2018 20:17 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionCommon Stock | 6,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-002360 · primarydocument.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,393.6773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 19:42 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 394.081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013664 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,172.6284 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 107.2545 shares acquired on March 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 20:25 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 339.466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000505 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,671.2929 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 93.093 shares acquired on December 15, 2017, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| October 01, 2017 Filed Oct 3, 2017 13:02 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 345.941 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028744 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,238.7339 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 94.328 shares acquired on September 15, 2017, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 15:34 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 349.748 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022683 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,798.4649 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 106.5933 shares acquired on June 15, 2017, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 12:25 UTC | HERSHEY CO HSY · Entity 795 | SaleCommon Stock | 4,500 | $115.45 | $519,534.00 |
DisclosureSEC source: 0001127602-17-020175 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,342.1236 F1 · price: This reflects the weighted average price for the shares, which were sold in multiple transactions at prices that ranged from $115.430 to $115.510. Upon the request of the SEC staff, the issuer or a security holder of the issuer, the reporting person undertakes to provide information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008225 · edgar.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 Underlying: Common Stock · 918 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 7,689 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001179110-17-008225 · edgar.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,689 Underlying: Common Stock · 7,689 shares Expires 2027-05-25 F1 · derivative.exercise_date: The option vests in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 08, 2017 Filed May 9, 2017 20:08 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantRestricted Stock Units · Derivative | 6,309 | $15.85 | $99,997.65 |
DisclosureSEC source: 0001562180-17-001903 · primarydocument.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,712 Underlying: Common Stock · 6,309 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F3 · deemedExecutionDate: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:08 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionRestricted Stock Units · Derivative | 5,485 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-001903 · primarydocument.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,485 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The RSUs were granted on May 9, 2016 and have a one year cliff vesting F1 · derivative.expiration_date: The RSUs were granted on May 9, 2016 and have a one year cliff vesting Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:08 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionCommon Stock | 5,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-001903 · primarydocument.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,459.4372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 14:21 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 343.249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013706 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,842.1236 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 109.6813 shares acquired on March 15, 2017, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| January 01, 2017 Filed Jan 3, 2017 19:35 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 362.249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-000129 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,389.1933 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 117.0104 shares acquired on December 15, 2016, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 20:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 28,820 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-16-031088 · edgar.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,820 Underlying: Common Stock · 28,820 shares Expires 2026-11-01 F1 · derivative.exercise_date: The option will vest in three equal annual installments beginning on November 1, 2017. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:56 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 354.815 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063931 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,909.9339 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 118.0896 shares acquired on September 15, 2016, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 384 | $22.73 | $8,728.32 |
DisclosureSEC source: 0000078003-08-000011 · she1664.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,933 Underlying: Common Stock · 384 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:53 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 387 | $23.10 | $8,939.70 |
DisclosureSEC source: 0000078003-07-000344 · she1656.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,549 Underlying: Common Stock · 387 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:22 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 337 | $23.76 | $8,007.12 |
DisclosureSEC source: 0000078003-07-000335 · she1648.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,162 Underlying: Common Stock · 337 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:14 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 1,551 | $23.29 | $36,122.79 |
DisclosureSEC source: 0000078003-07-000327 · she1640.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,825 Underlying: Common Stock · 1,551 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 352 | $24.61 | $8,662.72 |
DisclosureSEC source: 0000078003-07-000304 · she1628.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,274 Underlying: Common Stock · 352 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 335 | $25.00 | $8,375.00 |
DisclosureSEC source: 0000078003-07-000285 · she1618.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,922 Underlying: Common Stock · 335 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:42 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 363 | $24.43 | $8,868.09 |
DisclosureSEC source: 0000078003-07-000265 · she1599.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,587 Underlying: Common Stock · 363 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 352 | $24.29 | $8,550.08 |
DisclosureSEC source: 0000078003-07-000239 · she1586.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,224 Underlying: Common Stock · 352 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 287 | $24.84 | $7,129.08 |
DisclosureSEC source: 0000078003-07-000224 · she1576.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,872 Underlying: Common Stock · 287 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 1,477 | $23.53 | $34,753.81 |
DisclosureSEC source: 0000078003-07-000211 · she1567.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,585 Underlying: Common Stock · 1,477 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 371 | $23.51 | $8,722.21 |
DisclosureSEC source: 0000078003-07-000189 · she1558.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,108 Underlying: Common Stock · 371 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 336 | $25.91 | $8,705.76 |
DisclosureSEC source: 0000078003-07-000178 · she1549.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,737 Underlying: Common Stock · 336 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 339 | $25.57 | $8,668.23 |
DisclosureSEC source: 0000078003-07-000168 · she1537.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,401 Underlying: Common Stock · 339 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 330 | $26.47 | $8,735.10 |
DisclosureSEC source: 0000078003-07-000141 · she1528.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,062 Underlying: Common Stock · 330 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 05, 2007 Filed Jun 6, 2007 19:00 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 6,349 | $27.15 | $172,375.35 |
DisclosureSEC source: 0000078003-07-000132 · she1520.xml · nonDerivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,310 Read SEC document |
| June 05, 2007 Filed Jun 6, 2007 19:00 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 25,000 | $27.16 | $679,000.00 |
DisclosureSEC source: 0000078003-07-000132 · she1520.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615,659 Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 300 | $27.49 | $8,247.00 |
DisclosureSEC source: 0000078003-07-000130 · she1518.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,732 Underlying: Common Stock · 300 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 1,261 | $27.10 | $34,173.10 |
DisclosureSEC source: 0000078003-07-000120 · she1509.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,432 Underlying: Common Stock · 1,261 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 322 | $26.46 | $8,520.12 |
DisclosureSEC source: 0000078003-07-000100 · she1498.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,171 Underlying: Common Stock · 322 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 13, 2007 Filed Apr 17, 2007 15:22 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 309 | $26.67 | $8,241.03 |
DisclosureSEC source: 0000078003-07-000073 · she1476.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,849 Underlying: Common Stock · 309 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 30, 2007 Filed Apr 3, 2007 15:29 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 315 | $25.26 | $7,956.90 |
DisclosureSEC source: 0000078003-07-000063 · she1461.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,540 Underlying: Common Stock · 315 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 23, 2007 Filed Mar 27, 2007 20:06 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 28,708 | $25.66 | $736,647.28 |
DisclosureSEC source: 0000078003-07-000053 · she1454.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,760 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.